Dr. Jason M. Foster is a general surgeon and Professor in the Department of Surgery at the University of Nebraska Medical Center. He specializes in surgery for patients diagnosed with cancers of the gastrointestinal tract, peritoneal-based malignancies, and other cancers. Among his many skills is the complex surgical procedure called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy that begins with removing visible tumors from inside the abdominal cavity, and then bathing the cavity with a heated chemotherapy solution to kill any microscopic cancer cells left behind. This procedure has proven effective in the treatment of malignant peritoneal mesothelioma.
Dr. Foster limits his practice to oncologic diseases with the exception of conditions that might arise in patients he is already treating for cancer, or for special requests for complex general surgery conditions of the GI tract. His clinical interests and areas of expertise include the management of peritoneal surface malignancies that spread into the abdominal cavity including ovarian cancer, cancer of the appendix, colorectal cancer, and malignant peritoneal mesothelioma. He also treats patients with GI malignancies such as pancreatic and gastric cancer, skin tumors such as melanoma, and endocrine cancers including cancer of the thyroid. He has technical expertise in the use of intra-operative ultrasound, open and laparoscopic surgery, diagnostic and therapeutic endoscopy, and minimally invasive resection of tumors.
Education and Career
Dr. Foster earned his undergraduate degree at Bucknell University, where he earned a bachelor of science in Chemistry. He then moved on to Temple University School of Medicine, where he earned his medical degree, and completed his internship and residency in General Surgery at Case Western Reserve University /University Hospital of Cleveland. He completed a Basic Science Research Fellowship at Case Western Reserve followed by a Surgical Oncology fellowship at Roswell Park Cancer Institute and another fellowship in Gastrointestinal and Mixed Tumor Oncology there.
Following his fellowships he spent four years as an Assistant Professor of Surgery at Creighton University in Omaha, Nebraska, then joined the University of Nebraska Medical Center’s Department of Surgical Oncology.
Dr. Foster is actively engaged in clinical and basic science research for peritoneal surface malignancies and gastrointestinal cancer as well as investigation of the autocrine and paracrine biological effects of TGFβperturbations in colon cancer that facilitate and inhibit tumor progression. He is a frequent presenter at local, national, and international medical meetings.